Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence Study of Fenofibrate 130 mg Capsules in Healthy Male Subjects
NCT02306902Phase 1Completed
- Sponsor
- Ranbaxy Laboratories
- Start
- Oct 2009
- Primary completion
- Nov 2009
- Modality
- Small Molecules
01
Overview
Phase 1, randomised, open-label trial of fenofibrate in hypercholesterolemia and hypertriglyceridemia (2 arms), sponsored by Ranbaxy Laboratories. Primary endpoints: Area under the plasma concentration versus time curve and Peak Plasma Concentration. Started Oct 2009; status: completed.
02
Drugs
fenofibrate
03
Conditions
hypercholesterolemiahypertriglyceridemia
Beyond the preview
Go deeper on NCT02306902.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02306902.